Q3 2020
Released Nov 16, 2020, before the open
10-Q filed Nov 19, 2020, 50 days after period end · 0001493152-20-022041
Q3 2020 · 10-Q
Revenue$3.84M$3.84M +38.8% vs Q3 2019+6.0% vs Q2 2020
Net Income-$408.00K-$408.00K N/M vs Q3 2019N/M vs Q2 2020
EPS Diluted-$0.04-$0.04 N/M vs Q3 2019N/M vs Q2 2020
Gross Profit$1,042,000+24.9%
Operating Income-$567,000N/M
Operating Cash Flowderived-$481,000N/M
Free Cash Flowderived-$556,000N/M
Margins · derived
Gross margin27.1%−3.0 pt vs Q3 2019
Operating margin-14.8%+1.9 pt vs Q3 2019
Net margin-10.6%+4.8 pt vs Q3 2019
What the release said
The release
Same quarter
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $3.84M | $2.77M | $2.44M | $3.04M |
| Net Income | -$408.00K | -$428.00K | -$1.06M | -$777.00K |
| EPS Diluted | -$0.04 | -$0.04 | -$0.09 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR